Goldman Sachs upgraded Ingredion to Buy from Neutral with a price target of $135, up from $122, which represents 25% upside potential. Following the Q4 results, the shares are attractively valued, with estimates failing to give Ingredion full credit for rising balance sheet optionality and deployment of Korea divestiture proceeds, the analyst tells investors in a research note. The firm says the company’s operating execution and consistency has “notably improved” over the past 12-18 months, with productivity initiatives, cost control and specialty ingredient mix more than fully mitigating a challenging volume environment.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on INGR:
- Ingredion to Present at CAGNY 2024 Conference
- Ingredion price target raised to $125 from $120 at Oppenheimer
- Ingredion sees Q1 revenue down mid-single-digits, consensus $2.09B
- Ingredion Incorporated Reports Strong 2023 Fourth Quarter and Full-Year Results
- Ingredion sees FY24 adjusted EPS $9.15-$9.85, consensus $9.76
